PROCESSA PHARMACEUTICALS INC (PCSA)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$1.84-5.15%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · PCSA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenues | — | — | — | — | 0.0 | 0.0 | — | — | — | — | 0.0 | 0.1 | 0.1 | 0.3 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.1 | 0.1 | 0.3 |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | 0.0 | (0.0) | 0.0 | 0.1 |
| Operating Expenses & Income | ||||||||||||||
| Selling, General & Admin | — | — | — | — | — | — | — | — | 1.4 | — | 0.1 | 0.9 | 2.0 | 2.8 |
| R&D Expenses | — | — | — | 5.8 | 11.5 | 6.9 | 3.2 | 2.3 | 3.1 | 1.0 | 1.5 | 0.0 | 0.2 | 0.3 |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | — | — | (0.1) | 0.0 | (0.3) | (0.3) | (0.1) |
| Operating Income | (12.9) | (14.0) | (12.1) | (11.5) | (27.5) | (12.1) | (15.1) | (3.9) | (4.5) | (1.8) | (0.3) | (3.0) | (3.7) | (3.1) |
| Earnings from Continuing Operations | ||||||||||||||
| Interest Expense | — | — | — | — | — | 0.0 | 0.3 | 0.0 | 0.2 | 0.1 | 0.2 | 0.2 | 0.3 | (0.1) |
| Interest & Investment Income | — | 0.1 | 0.2 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | (0.0) | 0.3 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | (0.1) |
| EBT, Incl. Unusual Items | — | (13.6) | (11.9) | (11.1) | (27.4) | (12.0) | (15.4) | (4.0) | (4.7) | — | (0.3) | (3.0) | (3.7) | (3.1) |
| Income Tax Expense | — | — | — | — | — | (0.5) | (1.0) | (0.6) | (0.9) | — | (0.0) | (0.0) | (0.0) | (0.0) |
| Net Income | ||||||||||||||
| Net Income | (13.4) | (13.6) | (11.9) | (11.1) | (27.4) | (11.4) | (14.4) | (3.4) | (3.8) | (1.9) | (1.9) | (3.4) | (4.5) | (3.1) |
| Per Share | ||||||||||||||
| Basic EPS | (4.89) | (10.36) | (3.87) | (8.48) | (34.05) | (0.75) | — | — | — | (0.06) | — | — | — | — |
| Diluted EPS | (4.89) | (10.36) | (3.87) | (8.48) | (34.05) | — | — | — | — | (0.06) | — | — | — | — |
| Basic Weighted Avg Shares | 2.8 | 1.3 | 3.1 | 1.3 | 0.8 | 15.3 | — | — | — | 32.6 | — | — | — | — |
| Diluted Weighted Avg Shares | 2.8 | 1.3 | 3.1 | 1.3 | 0.8 | — | — | — | — | 32.6 | — | — | — | — |
| Supplemental | ||||||||||||||
| EBIT | (12.9) | (14.0) | (12.1) | (11.5) | (27.5) | (12.1) | (15.1) | (3.9) | (4.5) | (1.8) | (0.3) | (3.0) | (3.7) | (3.1) |
| Effective Tax Rate | — | — | — | — | — | 4.4% | 6.5% | 15.2% | 19.3% | — | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.